Michael T. Lotze

Michael T. Lotze

Corporate Officer/Principal at NURIX THERAPEUTICS, INC.

Health Technology
Consumer Services
Health Services

Profile

Michael T.
Lotze
is the founder of UPMC Cancer Institute.
He is currently the Chief Cellular Therapy Officer at Nurix Therapeutics, Inc. His former jobs include Director-Surgical Oncology at the University of Pittsburgh from 1990 to 2000, Vice President-Research at GlaxoSmithKline LLC, and CSO, Vice President-Research & Development at Iovance Biotherapeutics, Inc. from 2016 to 2017.
He received his doctorate degree from Northwestern University.

Michael T. Lotze active positions

CompaniesPositionStart
NURIX THERAPEUTICS, INC. Corporate Officer/Principal 31/05/2020
All active positions of Michael T. Lotze

Former positions of Michael T. Lotze

CompaniesPositionEnd
IOVANCE BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 20/08/2017
University of Pittsburgh Corporate Officer/Principal 31/12/1999
Corporate Officer/Principal -
Founder -
See the detail of Michael T. Lotze's experience

Training of Michael T. Lotze

Northwestern University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael T. Lotze's experience

Connections

96

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
IOVANCE BIOTHERAPEUTICS, INC.

Health Technology

NURIX THERAPEUTICS, INC.

Health Technology

Private companies2

Health Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Michael T. Lotze